{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Balchem Corp.
Balchem Corp. Experiences Valuation Adjustment Amidst Competitive FMCG Market Dynamics
Balchem Corp. has recently adjusted its valuation, showcasing a P/E ratio of 40 and a price-to-book value of 4.50. The company features a strong dividend yield of 44.23% and a ROCE of 14.27%. Its year-to-date performance contrasts with the S&P 500, indicating competitive challenges in the FMCG sector.
Is Balchem Corp. overvalued or undervalued?
As of October 17, 2025, Balchem Corp. is fairly valued with a P/E ratio of 40, but has underperformed the S&P 500 over the past year with a return of -14.21%, despite a positive return of 14.22% over the last three years.
Is Balchem Corp. overvalued or undervalued?
As of October 17, 2025, Balchem Corp. is fairly valued with a P/E ratio of 40, but has underperformed the S&P 500 with a one-year return of -14.21% compared to the index's 14.08%, and a three-year return of 14.22% versus the S&P 500's 81.19%.
Balchem Corp. Stock Hits 52-Week Low at USD 140.84
Balchem Corp. has reached a new 52-week low, reflecting a notable decline in its stock price over the past year. Despite this, the company maintains a solid market capitalization and demonstrates strong debt management. However, it faces challenges in achieving long-term growth, with underwhelming stock performance compared to the S&P 500.
Balchem Corp. Stock Hits 52-Week Low at USD 140.91
Balchem Corp. has reached a new 52-week low of USD 140.91, reflecting a 1-year performance decline of 6.52%. The company, with a market cap of USD 5,276 million and a P/E ratio of 40.00, has faced challenges in long-term growth despite a strong dividend yield and solid financial health indicators.
Balchem Corp. Stock Plummets to New 52-Week Low at $142.59
Balchem Corp., a small-cap FMCG company, recently hit a 52-week low, reflecting a 5.21% decline over the past year, contrasting with the S&P 500's gains. Despite steady net sales growth and positive quarterly results, the stock has underperformed, with a return of -16.89% in the last year.
Balchem Corp. Stock Plummets to New 52-Week Low of $144.87
Balchem Corp. has reached a new 52-week low, reflecting a notable decline in its stock performance over the past year. Despite a strong market capitalization and effective debt management, the company has struggled with long-term growth, underperforming compared to the S&P 500 in various time frames.
Balchem Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges
Balchem Corp., a small-cap FMCG company, has adjusted its valuation, with a P/E ratio of 40 and a price-to-book value of 4.50. Key metrics include a high dividend yield of 44.23% and a ROCE of 14.27%. Over the past year, the company has experienced a stock return of -14.34%.
Is Balchem Corp. technically bullish or bearish?
As of September 12, 2025, Balchem Corp. is in a bearish trend with moderate strength, indicated by bearish daily moving averages and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -4.02% compared to 12.22%.
Is Balchem Corp. overvalued or undervalued?
As of August 4, 2025, Balchem Corp. is considered overvalued with a P/E ratio of 40, an EV to EBITDA ratio of 23.46, and a Price to Book Value of 4.50, all significantly higher than industry averages and its peers, while also underperforming the S&P 500 with a one-year return of -11.13%.
Is Balchem Corp. technically bullish or bearish?
As of June 11, 2025, Balchem Corp. exhibits a mildly bearish technical trend, driven by bearish MACD and moving averages, despite mixed signals from the KST.
Is Balchem Corp. overvalued or undervalued?
As of June 12, 2025, Balchem Corp. is considered overvalued with a P/E ratio of 40 and an EV to EBITDA ratio of 28.90, significantly higher than its peers, while its stock has underperformed the S&P 500 year-to-date.
Who are in the management team of Balchem Corp.?
As of March 2022, Balchem Corp.'s management team includes Mr. Theodore Harris as Chairman, President, and CEO, with Dr. John Televantos serving as Lead Independent Director, alongside Independent Directors Mr. Paul Coombs, Mr. David Fischer, Mr. Daniel Knutson, and Ms. Joyce Lee.
What does Balchem Corp. do?
Balchem Corporation develops and markets specialty performance ingredients for various sectors, including food, pharmaceuticals, and industrial applications. As of March 2025, it reported net sales of $251 million and a market cap of $5.21 billion.
How big is Balchem Corp.?
As of Jun 18, Balchem Corp. has a market capitalization of $5.21 billion, with recent net sales of $964.54 million and a net profit of $136.54 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
